CLDI (Calidi Bio) Pangali Forward P/E
Calidi Biotherapeutics (CLDI) is developing a universal platform to combat various types of tumors, ensuring high business scalability. This innovative approach has earned the company an impeccable reputation and the trust of the professional community. The historical price-to-earnings ratio for the company on GURU.Markets demonstrates the effectiveness of using stem cells for stealth virus delivery, and the 0.00 metric determines this level.
Ringkesan rincian data analitis Calidi Bio (CLDI)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- informasi kapitalisasi buku:
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal Calidi Biotherapeutics|CLDI - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang modal Calidi Biotherapeutics|CLDI - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Calidi Biotherapeutics Inc.|CLDI - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Calidi Biotherapeutics|Rasio cepet calidibio.com
- rincian asil keuangan lan kelipatan valuasi:
CLDI - Asil keuangan resik|Proyeksi bathi mangsa ngarep Calidi Biotherapeutics|CLDI - Pangali rega marang bathi|Pangali Forward P/E Calidi Biotherapeutics|CLDI - Kapitalisasi marang bathi resik kanthi nimbang wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Calidi Biotherapeutics Inc.|CLDI - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Calidi Biotherapeutics|CLDI - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan calidibio.com|CLDI - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Calidi Biotherapeutics
Analisis fundamental perusahaan:Calidi Biotherapeutics, Inc.
Strong confidence within the oncology community regarding the Calidi Biotherapeutics (CLDI) platform is driving inflated expectations, which are directly reflected in the dynamics of the company's forward P/E ratio. This indicator compares current market value with projected earnings, allowing investors to timely detect stock overvaluation or margin compression due to rising costs by analyzing price volatility through the lens of this chart.
Analisis perusahaan pesaing
Prakiraan rega marang bathi ONC (BeiGene)|HALO (Halozyme Therapeutics, Inc.) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E RVMD (RevMed)|AAPG - Prakiraan rega marang bathi|CGON: Prakiraan rega marang bathi|URGN - Pangali Forward P/E|Bicara Therapeutics (BCAX) - Rega marang bathi mangsa ngarep|Personalis Inc - Pangali mangsa ngarep rega marang bathi|ERAS (Erasca Corp) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Delcath Corp DCTH|Pangali Forward P/E YMAB|Prakiraan rega marang bathi aurabiosciences.com AURA|Pangali Forward P/E CADL (Candel Therapeutics, Inc.)|Pangali Forward P/E Accuray Inc ARAY|SLS - Rega marang bathi mangsa ngarep|ACTU: Rega marang bathi mangsa ngarep|CTOR: Pangali Forward P/E|HURA - Kapitalisasi marang proyeksi bathi|TARA (Protara Therapeutics, Inc.) - Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep FATE (Fate Therapeutics Inc)|Pangali Forward P/E WHWK|Kapitalisasi marang proyeksi bathi tscan.com|Champions Oncology, Inc. - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi XBIT|CEL-SCI Corp - Pangali Forward P/E|OSTX: Rega marang bathi mangsa ngarep|RADX: Pangali Forward P/E|ARTV - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Adlai Nortye Ltd|Rasio prakiraan rega marang bathi verupharma.com VERU|Prakiraan rega marang bathi TPST (Tempest Therapeutics, Inc.)|Rasio kapitalisasi marang bathi mangsa ngarep XLO|Pangali Forward P/E RENB (Renovaro)|Pangali mangsa ngarep rega marang bathi MURA|Kairos Pharma Inc - Pangali Forward P/E|Rasio prakiraan rega marang bathi OnKure Therapeutics Inc|w2.cytomed.sg (GDTC) - Rega marang bathi mangsa ngarep|Curis - Pangali mangsa ngarep rega marang bathi|APLM (Apollomics Inc.) - Pangali Forward P/E|Pangali Forward P/E Tharimmune Corporation|Rega marang bathi mangsa ngarep Advanced Biomed Inc (ADVB)|GNPX: Rasio rega marang bathi sing dikarepake|Pangali Forward P/E SBFM (Sunshine Biopharma, Inc.)|Xenetic Biosciences Inc. (XBIO) - Rasio prakiraan rega marang bathi|SLRX: Prakiraan rega marang bathi|PPBT - Pangali Forward P/E|AONC (aoncology.com) - Prakiraan rega marang bathi|BGNE: Rasio kapitalisasi marang bathi mangsa ngarep|CKPT (Checkpoint Therapeutics, Inc.) - Pangali Forward P/E|elevationoncology.com (ELEV) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E ICAD|Prakiraan rega marang bathi ikenaoncology.com IKNA|Rega marang bathi mangsa ngarep Notable Labs, Ltd. NTBL|Kapitalisasi marang proyeksi bathi Viracta Therapeutics Inc. (VIRX)|MorphoSys - Pangali Forward P/E|NAYA Biosciences Inc (NAYA) - Prakiraan rega marang bathi|Ascentage Pharma Group Ltd (AAPGV) - Rega marang bathi mangsa ngarep
